Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
gene therapy
genentech
3
×
life sciences
national blog main
cell therapy
fda
national
national top stories
new york top stories
novartis
san francisco top stories
acetylon pharmaceuticals
acute lymphoblastic leukemia
ambys medicines
billy dunn
biogen
boston blog main
boston top stories
catalyst healthcare consultants
clinical trials
constellation pharmaceuticals
deals
drug information association
drug prices
drug pricing
elevatebio
europe top stories
evrysdi
holger willenbring
ionis pharmaceuticals
ipo
jeffrey tong
juan carlos izpisua belmonte
karen walker
keith dionne
kymriah
liver disease
markus grompe
martin burke
What
new
3
×
fda
therapy
aiming
ambys
approved
atrophy
big
biotech
chemistry
cmc
consistent
control
controls
daily
deadly
deal
debuted
diseases
drug
ensure
evrysdi
formed
friday
future
gene
green
home
intended
lack
launch
lights
liquid
liver
make
manufacturing
medicine
medicines
muscular
needed
Language
unset
Current search:
genentech
×
biotech
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
